Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 29;12:863655. doi: 10.3389/fonc.2022.863655

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Greco, Pares, Pimentel, Louro, Nunes, Kociolek, Stroom, Vieira, Mateus, Cardoso, Soares, Marques, Freitas, Coelho and Fuks

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

⁶⁸PSMA-detected relapse in a patient who received 5-fraction SABR. (A) Fused ⁶⁸PSMA-PET/CT and planning MRI show pretreatment location of ⁶⁸PSMA-detected dominant intraprostatic lesion (DIL) encompassed within the CTV and receiving the full 45 Gy prescription dose; (B) fused ⁶⁸PSMA-PET/CT acquired at the occurrence of biochemical relapse with the planning MRI scan shows persistence/recurrence of the DIL at the initial site.